首页> 外文期刊>Stem cell reviews and Reports >Stage-Specific Cardiomyocyte Differentiation Method for H7 and H9 Human Embryonic Stem Cells
【24h】

Stage-Specific Cardiomyocyte Differentiation Method for H7 and H9 Human Embryonic Stem Cells

机译:H7和H9人胚胎干细胞的特定阶段心肌细胞分化方法

获取原文
获取原文并翻译 | 示例
           

摘要

The generation of cardiomyocytes from human embryonic stem cells (hESC) boasts a variety of potential applications including cell transplantation for myocardial repair. Unfortunately, advancements in the field has been challenged by the low efficiency of cardiomyocyte differentiation from hESC. Recently, Kattman et al. 2011 showed that individual hESC lines require a precise balance of the Activin A and BMP4 signaling for efficient cardiac differentiation. This group also presented differentiation protocols for several human and mouse ESC lines, however; two of the most utilized hESC lines, the H9 and H7 ESC, were not included. Here, we provide protocols, based on the work from Kattman et al. 2011, for generating cardiomyoctyes from H7 and H9 hESC. These hESC line-specific protocols reproducibly direct approximately 50 % of hESC towards the cardiac lineage.
机译:由人类胚胎干细胞(hESC)产生心肌细胞具有多种潜在应用,包括用于心肌修复的细胞移植。不幸的是,该领域的进展一直受到来自hESC的心肌细胞分化效率低的挑战。最近,Kattman等人。 2011年显示,单个hESC品系需要有效平衡Activin A和BMP4信号以实现有效的心脏分化。该小组还提出了几种人类和小鼠ESC系的分化方案。不包括两个最常用的hESC系,即H9和H7 ESC。在这里,我们根据Kattman等人的工作提供协议。 2011,用于从H7和H9 hESC生成心肌。这些特定于hESC系的方案可重复地将大约50%的hESC引向心脏谱系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号